Viewing Study NCT04796857


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-01 @ 4:57 PM
Study NCT ID: NCT04796857
Status: UNKNOWN
Last Update Posted: 2021-03-15
First Post: 2021-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL
Sponsor: Huiqiang Huang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module